Phio Pharmaceuticals Corp. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
King Of Prussia, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Phio Pharmaceuticals Corp. has filed 870 SEC EDGAR filings since 25 Oct 2011

SEC filing history

Showing 551-575 of 870 matching filings.

Per page
25
Current page
23
8-K File 001-36304

FORM 8-K

Filing date
30 Mar 2017
Reporting date
30 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

8-K

Filing date
29 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

FORM 8-K

Filing date
28 Mar 2017
Reporting date
28 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2017
Reporting date
17 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Feb 2017
Reporting date
17 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86901

SC 13G filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86901

SC 13G filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86901

SC 13G/A filing

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2017
Reporting date
08 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36304

FORM 8-K

Filing date
03 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Feb 2017
Reporting date
01 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-215871

FORM S-8

Filing date
02 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-215870

S-8

Filing date
02 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jan 2017
Reporting date
25 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jan 2017
Reporting date
19 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
17 Jan 2017
Reporting date
06 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86901

SCHEDULE 13G

Filing date
12 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-86901

SABBY 13G-A RXII 1.12.17

Filing date
12 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .